Triferic
NDC Package 57278-315-02
Package Information
Triferic is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Marketed by Rockwell Medical, Inc, this product is identified by NDC 57278-315 and is authorized under FDA application NDA208551.
Identification & Billing
- RxCUI: 1790866 - ferric pyrophosphate (as iron) 272 MG hemodialysis Injection
- RxCUI: 1790866 - ferric pyrophosphate citrate 272 MG Injection
- RxCUI: 1790866 - ferric pyrophosphate (as elemental iron) 272 MG hemodialysis Injection
- RxCUI: 1790869 - Triferic (iron) 272 MG hemodialysis Injection
- RxCUI: 1790869 - ferric pyrophosphate citrate 272 MG Injection [Triferic]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 57278 - Rockwell Medical, Inc
- 57278-315 - Triferic
- 57278-315-02 - 100 PACKET in 1 CARTON / 1 POWDER in 1 PACKET
- 57278-315 - Triferic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 57278-315-02 identifies a specific commercial package of 100 packet in 1 carton / 1 powder in 1 packet of Triferic, labeled by Rockwell Medical, Inc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rockwell Medical, Inc on April 25, 2016. The current certification is valid through December 31, 2022.
How is this Rockwell Medical, Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 57278031502. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
